Company registration number 12658726 (England and Wales)
MOON MEDICAL LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 JUNE 2024
PAGES FOR FILING WITH REGISTRAR
MOON MEDICAL LIMITED
COMPANY INFORMATION
Director
Dr A Moon
Company number
12658726
Registered office
Rose Cottage
Perrymill Lane
Sambourne
Warwickshire
B96 6PD
Accountants
Ormerod Rutter Limited
The Oakley
Kidderminster Road
Droitwich
Worcestershire
WR9 9AY
Bankers
NatWest Bank Plc
1 The Cross
Worcester
Worcestershire
WR1 3PR
MOON MEDICAL LIMITED
CONTENTS
Page
Accountants' report
1
Balance sheet
2 - 3
Notes to the financial statements
4 - 6
MOON MEDICAL LIMITED
ACCOUNTANTS' REPORT TO THE DIRECTOR ON THE PREPARATION OF THE UNAUDITED STATUTORY FINANCIAL STATEMENTS OF MOON MEDICAL LIMITED FOR THE YEAR ENDED 30 JUNE 2024
- 1 -

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of Moon Medical Limited for the year ended 30 June 2024 which comprise, the balance sheet and the related notes from the company’s accounting records and from information and explanations you have given us.

 

As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed at https://www.icaew.com/regulation.

This report is made solely to the board of directors of Moon Medical Limited, as a body, in accordance with our terms of engagement. Our work has been undertaken solely to prepare for your approval the financial statements of Moon Medical Limited and state those matters that we have agreed to state to the board of directors of Moon Medical Limited, as a body, in this report in accordance with ICAEW Technical Release 07/16 AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Moon Medical Limited and its board of directors as a body, for our work or for this report.

It is your duty to ensure that Moon Medical Limited has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and loss of Moon Medical Limited. You consider that Moon Medical Limited is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or a review of the financial statements of Moon Medical Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.

Ormerod Rutter Limited
27 September 2024
Chartered Accountants
The Oakley
Kidderminster Road
Droitwich
Worcestershire
WR9 9AY
MOON MEDICAL LIMITED
BALANCE SHEET
AS AT
30 JUNE 2024
30 June 2024
- 2 -
2024
2023
Notes
£
£
£
£
Fixed assets
Tangible assets
3
44,136
55,170
Current assets
Debtors
4
27,700
33,504
Cash at bank and in hand
268
4,115
27,968
37,619
Creditors: amounts falling due within one year
5
(8,611)
(7,861)
Net current assets
19,357
29,758
Total assets less current liabilities
63,493
84,928
Creditors: amounts falling due after more than one year
6
(32,674)
(39,212)
Provisions for liabilities
7
(6,436)
(9,362)
Net assets
24,383
36,354
Capital and reserves
Called up share capital
9
1
1
Profit and loss reserves
24,382
36,353
Total equity
24,383
36,354

The director of the company has elected not to include a copy of the profit and loss account within the financial statements.true

For the financial year ended 30 June 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The director acknowledges her responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The member has not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

MOON MEDICAL LIMITED
BALANCE SHEET (CONTINUED)
AS AT
30 JUNE 2024
30 June 2024
- 3 -
The financial statements were approved and signed by the director and authorised for issue on 27 September 2024
Dr A Moon
Director
Company registration number 12658726 (England and Wales)
MOON MEDICAL LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 JUNE 2024
- 4 -
1
Accounting policies
Company information

Moon Medical Limited is a private company limited by shares incorporated in England and Wales. The registered office is Rose Cottage, Perrymill Lane, Sambourne, Warwickshire, B96 6PD.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Fixtures and fittings
20% on reducing balance
Motor vehicles
20% on reducing balance
1.3
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

 

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

MOON MEDICAL LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 JUNE 2024
1
Accounting policies
(Continued)
- 5 -
1.4
Leases

Leases are classified as finance leases whenever the terms of the lease transfer substantially all the risks and rewards of ownership to the lessees. All other leases are classified as operating leases.

 

Assets held under finance leases are recognised as assets at the lower of the assets fair value at the date of inception and the present value of the minimum lease payments. The related liability is included in the balance sheet as a finance lease obligation. Lease payments are treated as consisting of capital and interest elements. The interest is charged to profit or loss so as to produce a constant periodic rate of interest on the remaining balance of the liability.

2
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2024
2023
Number
Number
Total
1
1
3
Tangible fixed assets
Fixtures and fittings
Motor vehicles
Total
£
£
£
Cost
At 1 July 2023 and 30 June 2024
3,881
58,379
62,260
Depreciation and impairment
At 1 July 2023
1,398
5,692
7,090
Depreciation charged in the year
497
10,537
11,034
At 30 June 2024
1,895
16,229
18,124
Carrying amount
At 30 June 2024
1,986
42,150
44,136
At 30 June 2023
2,483
52,687
55,170
4
Debtors
2024
2023
Amounts falling due within one year:
£
£
Other debtors
27,700
33,504
MOON MEDICAL LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 JUNE 2024
- 6 -
5
Creditors: amounts falling due within one year
2024
2023
£
£
Trade creditors
96
71
Other creditors
8,515
7,790
8,611
7,861
6
Creditors: amounts falling due after more than one year
2024
2023
£
£
Other creditors
32,674
39,212
7
Provisions for liabilities
2024
2023
£
£
Deferred tax liabilities
6,436
9,362
8
Secured debts
The following secured debts are included within creditors:
2024
2023
£
£
Hire purchase contracts
39,213
45,751
Hire purchase contracts are secured against the assets to which they relate.
9
Called up share capital
2024
2023
2024
2023
Ordinary share capital
Number
Number
£
£
Issued and fully paid
Ordinary of £1 each
1
1
1
1
10
Ultimate controlling party

The ultimate controlling party is Dr A Moon.

2024-06-302023-07-01false27 September 2024CCH SoftwareCCH Accounts Production 2024.210No description of principal activityDr A Moonfalsefalse126587262023-07-012024-06-3012658726bus:Director12023-07-012024-06-3012658726bus:RegisteredOffice2023-07-012024-06-3012658726bus:Agent12023-07-012024-06-30126587262024-06-30126587262023-06-3012658726core:FurnitureFittings2024-06-3012658726core:MotorVehicles2024-06-3012658726core:FurnitureFittings2023-06-3012658726core:MotorVehicles2023-06-3012658726core:CurrentFinancialInstrumentscore:WithinOneYear2024-06-3012658726core:CurrentFinancialInstrumentscore:WithinOneYear2023-06-3012658726core:Non-currentFinancialInstrumentscore:AfterOneYear2024-06-3012658726core:Non-currentFinancialInstrumentscore:AfterOneYear2023-06-3012658726core:CurrentFinancialInstruments2024-06-3012658726core:CurrentFinancialInstruments2023-06-3012658726core:ShareCapital2024-06-3012658726core:ShareCapital2023-06-3012658726core:RetainedEarningsAccumulatedLosses2024-06-3012658726core:RetainedEarningsAccumulatedLosses2023-06-3012658726core:FurnitureFittings2023-07-012024-06-3012658726core:MotorVehicles2023-07-012024-06-30126587262022-07-012023-06-3012658726core:FurnitureFittings2023-06-3012658726core:MotorVehicles2023-06-30126587262023-06-3012658726core:WithinOneYear2024-06-3012658726core:WithinOneYear2023-06-3012658726core:Non-currentFinancialInstruments2024-06-3012658726core:Non-currentFinancialInstruments2023-06-3012658726bus:PrivateLimitedCompanyLtd2023-07-012024-06-3012658726bus:SmallCompaniesRegimeForAccounts2023-07-012024-06-3012658726bus:FRS1022023-07-012024-06-3012658726bus:AuditExemptWithAccountantsReport2023-07-012024-06-3012658726bus:FullAccounts2023-07-012024-06-30xbrli:purexbrli:sharesiso4217:GBP